Clinical Trial

Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by pathologic intraneuronal alpha-synuclein-positive Lewy bodies and neuronal cell loss. The cardinal clinical symptoms and signs of PD are bradykinesia, rigidity, tremor, postural instability, and freezing attacks. The prevalence of PD increases with age, affecting 1-2% of the population over the age of 65 years, and 3% of those over 85 years. Restless legs syndrome (RLS) represents disturbing symptoms in lower limbs that lead to the urge to move, occurring in rest periods. Movements can partially or completely relieve these abnormal feelings. In 2014, the International RLS Study Group (IRLSSG) established five mandatory criteria for the diagnosis of RLS. Several studies supported that RLS and PD may share pathophysiological mechanisms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-10.
Status change: Not Yet Recruiting → Recruiting 2025-05-12
Trial Details
NCT Number NCT06684782
Lead Sponsor Siriraj Hospital
Conditions Restless Legs Syndrome
Enrollment 310 participants
Start Date 2024-12-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-15